Search results
Latest ESO Guidelines. European Stroke Organisation (ESO) and European Society for Minimally Invasive Neurological Therapy (ESMINT) Guideline on Acute Management of Basilar Artery Occlusion. Presentation Slide Deck. Watch the Video.
- ESO Guideline Development Webinar
Please contact guidelines@eso-stroke.org for further...
- ESO Guideline Board
Guidelines are helpful in everyday clinical medical...
- Membership
ESO Fellow: 150: Fellows must be nominated based on a...
- Disclaimer
The information contained in this website is for general...
- Emerging Leader Programme
A defined framework of ESO educational activities required...
- ESO Guideline Development Webinar
19 lut 2021 · The European Stroke Organisation (ESO) guidelines on intravenous thrombolysis (IVT) for acute ischaemic stroke provides forty recommendations on the use of thrombolytic drugs. The module working group, led by Guillaume Turc, William Whiteley and the late Eivind Berge, has written evidence-based recommendations and expert consensus statements ...
2021 European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines. Acute Stroke. 2023 — European Stroke Organisation (ESO) Expedited Recommendation on tenecteplase for acute ischaemic stroke ️ Watch the video ⬇️ Download the slides.
These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist physicians in their clinical decisions with regard to intravenous thrombolysis for acute ischaemic stroke.
19 lut 2021 · These European Stroke Organisation (ESO) guidelines provide evidence-based recommendations to assist physicians in their clinical decisions with regard to intravenous thrombolysis for acute ischaemic stroke.
The aim of the present European Stroke Organisation guideline is to provide clinically useful evidence-based recommendations on the management of extracranial artery dissection (EAD) and intracranial artery dissection (IAD).
30 mar 2022 · This European Stroke Organisation (ESO) guideline provides evidence-based recommendations on pharmacological management of blood pressure (BP), diabetes mellitus, lipid levels and antiplatelet therapy for the prevention of recurrent stroke and other important outcomes in people with ischaemic stroke or transient ischaemic attack (TIA).